TERN PLC

Regulatory Filings • Jul 26, 2019

25-Jul-2019 / 15:25 GMT/BST

Dissemination of a RegulatoryAnnouncement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

Thisannouncement contains inside informaon for the purposes of Arcle 7 ofEU Regulaon 596/2014.

25 July 2019

Tern Plc("Tern" or the "Company")

New commercial order forFundamentalVR

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that FVRVS Limited ("FundamentalVR"),aleadingvirtual reality ("VR") trainingand dataanalysis technology pla3orm,and one ofTern's exisng por3olio companies, has secured an order of approximately £0.5 million to create an addional VR simulaon, for one of the world's leading pharmaceucal companies.This is the second order in a planned series of virtual reality simulaons specifically designed to support that pharmaceucal company'sambions to accelerate the safe and compliant use of their products.The majority of this order will be completed during 2019.

FundamentalVR's award winning pla3orm combines immersive virtual reality with cu;ng-edge hapcs (the sense of touch) to create low-cost and scalable simulation experiences, to offera new way to allow skills development for surgeonsand medical professionals.

This second implementaon will be used to teach surgeons how to pracce safe administraon of the product, enablingthe individual surgeon to benchmark their skillsagainstarecommended approach to provide datathey can use to improve paent outcomes.

The mul-stage virtual reality approach has become the template for product educaon by the pharmaceucal client, ulising FundamentalVR's virtual reality with hapcs pla3orm.

Tern CEO, Al Sisto, said, "We're pleased to note this follow-on order forFundamentalVR. We have found that the adopon of its pla3orm has been key in accelerating the competency and confidence surgeons now have when it comes to using medical devices and praccing innovave medical procedures, with FundamentalVR having the ability to shorten the me for market acceptance. We look forward to announcing further adopon of the pla3orm in due course."

**ENDS**

Enquiries

Tern plc Al Sisto, CEO Sarah Payne,Finance Director	Via Newgate Communicaons
Allenby Capital Limited (Nomad and Joint broker) David Worlidge/Alex Brearley	Tel: 020 3328 5656
Whitman Howard (Joint broker) Nick Lovering/ChristopherFurness	Tel: 020 7659 1234
Newgate Communica+ons	Tel: 020 3757 6880

PR Elisabeth Cowell/Fiona Norman

ISIN: GB00BFPMV798 Category Code:MSCH TIDM: TERN LEICode: 2138005F87SODHL9CQ36 Sequence No.: 14688 EQS News ID: 847089

End ofAnnouncementEQS News Service